Nephritic syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Approximately 25% of patients with acute [[glomerulonephritis]] present with nephritic syndrome.<ref>{{cite book | last = Chang |first = A | authorlink = | coauthors = Pradeep VK, Alexander JJ | title = Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease | publisher = Springer |date = 2009 | location = | pages = 711-6 | url = | doi = | id = | isbn = }}</ref> Acute glomerulonephritis accounts for 10-15% of [[glomerular]] diseases in the USA.<ref>{{cite book | last = Chang |first = A | authorlink = | coauthors = Pradeep VK, Alexander JJ | title = Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease | publisher = Springer |date = 2009 | location = | pages = 711-6 | url = | doi = | id = | isbn = }}</ref> | Approximately 25% of patients with acute [[glomerulonephritis]] present with nephritic syndrome. Acute glomerulonephritis accounts for 10-15% of [[glomerular]] diseases in the USA. The reported [[incidence]] of glomerulonephritis in adults varies between 0.2 to 2.5/100,000 annually with a male to female ratio reaching 2 to 1. The most common cause of glomerulonephritis worldwide is [[IgA nephropathy]] ([[Berger disease]]). Approximately 25-30% of patients eventually develop [[end-stage renal disease]] ([[ESRD]]). The yearly variation of incidence of glomerulonephritis is not validated. While some studies report a decrease in the incidence due to improved healthcare and socioeconomic status, others report an increase in the reported incidence due to increased number of biopsies. Additionally, the true incidence is difficult to predict because the disease might present subclinically. | ||
==Epidemiology and Demographics== | |||
* Approximately 25% of patients with acute [[glomerulonephritis]] present with nephritic syndrome.<ref>{{cite book | last = Chang |first = A | authorlink = | coauthors = Pradeep VK, Alexander JJ | title = Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease | publisher = Springer |date = 2009 | location = | pages = 711-6 | url = | doi = | id = | isbn = }}</ref> | |||
* Acute glomerulonephritis accounts for 10-15% of [[glomerular]] diseases in the USA.<ref>{{cite book | last = Chang |first = A | authorlink = | coauthors = Pradeep VK, Alexander JJ | title = Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease | publisher = Springer |date = 2009 | location = | pages = 711-6 | url = | doi = | id = | isbn = }}</ref> | |||
* The reported [[incidence]] of glomerulonephritis in adults varies between 0.2 to 2.5/100,000 annually with a male to female ratio reaching 2 to 1.<ref name="pmid21068142">{{cite journal| author=McGrogan A, Franssen CF, de Vries CS| title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. | journal=Nephrol Dial Transplant | year= 2011 | volume= 26 | issue= 2 | pages= 414-30 | pmid=21068142 | doi=10.1093/ndt/gfq665 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21068142 }} </ref> | |||
* The most common cause of glomerulonephritis worldwide is [[IgA nephropathy]] ([[Berger disease]]). Approximately 25-30% of patients eventually develop [[end-stage renal disease]] ([[ESRD]]).<ref name="pmid21068142" /> | |||
* he yearly variation of incidence of glomerulonephritis is not validated. While some studies report a decrease in the incidence due to improved healthcare and socioeconomic status, others report an increase in the reported incidence due to increased number of biopsies.<ref name="pmid21068142" /> | |||
* The true incidence is difficult to predict because the disease might present subclinically. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 17:39, 3 May 2018
|
Nephritic syndrome Microchapters |
|
Treatment |
|---|
|
Case Studies |
|
Nephritic syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Nephritic syndrome epidemiology and demographics |
|
Nephritic syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Nephritic syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, Serge Korjian
Overview
Approximately 25% of patients with acute glomerulonephritis present with nephritic syndrome. Acute glomerulonephritis accounts for 10-15% of glomerular diseases in the USA. The reported incidence of glomerulonephritis in adults varies between 0.2 to 2.5/100,000 annually with a male to female ratio reaching 2 to 1. The most common cause of glomerulonephritis worldwide is IgA nephropathy (Berger disease). Approximately 25-30% of patients eventually develop end-stage renal disease (ESRD). The yearly variation of incidence of glomerulonephritis is not validated. While some studies report a decrease in the incidence due to improved healthcare and socioeconomic status, others report an increase in the reported incidence due to increased number of biopsies. Additionally, the true incidence is difficult to predict because the disease might present subclinically.
Epidemiology and Demographics
- Approximately 25% of patients with acute glomerulonephritis present with nephritic syndrome.[1]
- Acute glomerulonephritis accounts for 10-15% of glomerular diseases in the USA.[2]
- The reported incidence of glomerulonephritis in adults varies between 0.2 to 2.5/100,000 annually with a male to female ratio reaching 2 to 1.[3]
- The most common cause of glomerulonephritis worldwide is IgA nephropathy (Berger disease). Approximately 25-30% of patients eventually develop end-stage renal disease (ESRD).[3]
- he yearly variation of incidence of glomerulonephritis is not validated. While some studies report a decrease in the incidence due to improved healthcare and socioeconomic status, others report an increase in the reported incidence due to increased number of biopsies.[3]
- The true incidence is difficult to predict because the disease might present subclinically.
References
- ↑ Chang, A (2009). Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease. Springer. pp. 711–6. Unknown parameter
|coauthors=ignored (help) - ↑ Chang, A (2009). Glomerulonephritis, Membranopoliferative In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease. Springer. pp. 711–6. Unknown parameter
|coauthors=ignored (help) - ↑ 3.0 3.1 3.2 McGrogan A, Franssen CF, de Vries CS (2011). "The incidence of primary glomerulonephritis worldwide: a systematic review of the literature". Nephrol Dial Transplant. 26 (2): 414–30. doi:10.1093/ndt/gfq665. PMID 21068142.